Vutiglabridin, CAS [[1800188-47-9]]

Artikelnummer: TGM-T61268
Artikelname: Vutiglabridin, CAS [[1800188-47-9]]
Artikelnummer: TGM-T61268
Hersteller Artikelnummer: T61268
Alternativnummer: TGM-T61268-1MLX10MM(INDMSO),TGM-T61268-1MG,TGM-T61268-5MG,TGM-T61268-10MG,TGM-T61268-25MG,TGM-T61268-50MG,TGM-T61268-100MG
Hersteller: TargetMol
Kategorie: Biochemikalien
Alternative Synonym: HSG4112
Vutiglabridin (HSG4112) is a novel and safe modulator of PON2, a racemic compound. vutiglabridin is an optimized structural analogue of Glabridin and is superior to Glabridin in terms of weight loss and chemical stability. vutiglabridin ameliorates mptp-induced neurodegeneration in Parkinsons disease mice by targeting mitochondrial paraoxonase-2. Vutiglabridin is a clinical phase 2 drug for the treatment of obesity and has therapeutic effects on p-mitochondrial PON2 in a PD model. vutiglabridin penetrates the brain, binds PON2, and restores 1-methyl-4-phenylpyridine (MPP*)-induced neuroblastoma in SH-SY5Y Vutiglabridin significantly attenuated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dyskinesia and dopaminergic neuronal damage in mice modeled with PD in mouse experiments.
Molekulargewicht: 354.44
Reinheit: 99.07%
CAS Nummer: [1800188-47-9]
Formel: C22H26O4
Target-Kategorie: ROS|||Phosphatase|||Others|||PPAR|||Antibacterial
T61268